Skip to main content

Table 3 Phenotyping of CD14 − CD16 ++ , CD14 + CD16 + and CD14 + CD16 low/- cell populations

From: Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity

Cell marker

CD14 − CD16 ++ average MFI (SE)

CD14 + CD16 + average MFI (SE)

CD14 + CD16 low/- average MFI (SE)

 

CD1b

129 (28)a

113 (12)

54 (7)b

Antigen presentation Co-stimulatory molecules

CD80

2349 (378)

1590 (119)

1889 (66)

Antigen presentation Co-stimulatory molecules

CD86

1226 (172)a

2941 (291)

2403 (403)b

Antigen presentation Co-stimulatory molecules

CD40

9166 (1548)

7896 (1224)

6839 (967)

Antigen presentation Co-stimulatory molecules

MHC DR

46 014 (12 130)

63 800 (13650)

32 720 (9057)

Antigen presentation Co-stimulatory molecules

CD11b

20 755 (4334)a

32 631 (5299)

47 893 (9406)b

Antigen presentation Co-stimulatory molecules

CD11c

7575 (3295)

12 828 (4748)

21 093 (11339)

Antigen presentation Co-stimulatory molecules

CD3

<10a

43 (11)b

36 (8)b

Lymphoid cell markers

CD4

<10

<10

<10

Lymphoid cell markers

CD8α

<10

28 (3)

14 (4)

Lymphoid cell markers

CD8β

<10

10 (5)

<10

Lymphoid cell markers

CD21

618 (140)A

247 (23)B

136 (18)B

Lymphoid cell markers

NKp46

38 (16)

34 (3)

17 (2)

Lymphoid cell markers

CD26

147 (37)

151 (22)

110 (21)

Lymphoid cell markers

CD172a

96 077 (31018)

100 076 (31620)

89 046 (28726)

Myeloid cell markers

CD206

649 (260)

1533 (389)a

191 (32)b

Myeloid cell markers

TLR2

92 (25)

299 (41)

261 (96)

Myeloid cell markers

CD163

409 (68)A

1273 (58)B

1898 (222)C

Myeloid cell markers

CD16

18 344 (1448)A

4039 (607)B

366 (99)C

Myeloid cell markers

CD14

20 (16)A

978 (78)B

1748 (337)B

Myeloid cell markers

  1. Three colour flow cytometry was carried out on PBMC stained with selected mAb (details in Table 1) as primary antibodies and stained with an isotype-specific R:PE conjugated secondary mAb, followed by directly conjugated mAbs CD16 and CD14. Following live/dead and singlets gating, PBMC were then gated based on the expression of CD16 and CD14 as CD14-CD16++, CD14+CD16+ and CD14+ CD16low/- as shown in Figure 2 and expression of the markers was then analysed. Geometric mean fluorescence intensity (MFI), corrected with the MFI of its corresponding FMO, for each of the molecules is shown in the table as an arithmetic mean and standard error -SE (n = 4). Different letters denote significant difference in marker expression levels (MFI) between the three myeloid populations (p < 0.05 (lower case) and p < 0.001 (upper case)).